A randomized controlled trial of transcatheter arterial chemoembolization(TACE) in patients with advanced hepatocellular:Comparison of periodical TACE versus recurrence time TACE
Not Applicable
- Conditions
- advanced hepatocellular carcinoma(HCC)
- Registration Number
- JPRN-UMIN000000690
- Lead Sponsor
- Department of Clinical Research, National Hospital Organization Iwakuni Clinical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 78
Inclusion Criteria
Not provided
Exclusion Criteria
a)patients with HCC suitable for curative treatment b)Child C c)allergy of contrast medium d)list of living donor liver transplantation e)portal vein tumor thrombus f)extrahepatic metastasis g)sponteneous tumor rupture h)The patients whom judged to be inadequate by clinical trial liability or clinical trial allotment doctor.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method cumulative survival rate
- Secondary Outcome Measures
Name Time Method